A possible explanation is that although HGF/c-Met signaling is required for triggering EMT of HCC, c-Met signaling may be down regulated after the EMT process is completed and compensated for by other RTK pathways for sustaining the mesenchymal phenotype and high motility. The gene discussed is HGF; the disease is hepatocellular carcinoma.